Immune-inflammatory endotypes of chronic rhinosinusitis: from epithelial alarmins to personalized therapy

• by Hanxiong Li, Longting Wang, Dingbo Li

• July 17, 2026

CRS Trial Reveals Surgery Divide

MACRO qualitative study explores why patients differ in attitudes toward endoscopic sinus surgery.

• by Jess Allerton

• March 18, 2026

• 3 min

Multi-omics integration and in vitro validation identify IL4R, IMPA2, and PRR4 as key therapeutic targets in chronic rhinosinusitis with nasal polyps

• by Bo Wei, Weigang Gan, Jiaxin Li, Feng Wang, Jun Wang, Binbin Wang, Jiaoyu He, Feng Liu

• June 15, 2026

Hypotensive Agents Reduce Bleeding in ESS

Diltiazem, esmolol, dexmedetomidine, labetalol, and clonidine were associated with improved surgical field quality and comparable safety profiles

• by Olivia Anderson

• January 30, 2026

• 3 min